Welcome to CDC stacks | A Prospective, Multicenter Study of Laboratory Cross-Contamination of Mycobacterium tuberculosis Cultures - 14030 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A Prospective, Multicenter Study of Laboratory Cross-Contamination of Mycobacterium tuberculosis Cultures
  • Published Date:
    Nov 2002
  • Source:
    Emerg Infect Dis. 8(11):1260-1263.
Filetype[PDF-201.33 KB]


Details:
No Related Documents.
You May Also Like:
  1. DNA Fingerprinting of Mycobacterium tuberculosis: Lessons Learned and Implications for the Future
    Personal Author:
    McNabb, Scott J. N.; Braden, Christopher R.; Navin, Thomas R.;
    Published:
    Nov 2002
    Source:
    Emerg Infect Dis. 8(11):1314-1319.
    Description:
    DNA fingerprinting of Mycobacterium tuberculosis--a relatively new laboratory technique--offers promise as a powerful aid in the prevention and control of tuberculosis (TB). Established in 1996 by the Centers for Disease Control and Prevention (CDC),...
    File Type:
    Filetype[PDF - 249.76 KB]
  2. Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel
    Personal Author:
    Levy, Isaac; Grisaru-Soen, Galia; Lerner-Geva, Liat; Kerem, Eitan; Blau, Hana; Bentur, Lea; Aviram, Micha; Rivlin, Joseph; Picard, Elie; Lavy, Anita; Yahav, Yakov; Rahav, Galia;
    Published:
    Mar 2008
    Source:
    Emerg Infect Dis. 14(3):378-384.
    Description:
    This 2-year cross-sectional evaluation of nontuberculous mycobacterial (NTM) infections involved all Israeli medical centers that treat cystic fibrosis patients. The study comprised 186 patients whose sputum was analyzed for NTM. The prevalence of NT...
    File Type:
    Filetype[PDF - 178.25 KB]
  3. Prevalence of Nontuberculous Mycobacteria in Cystic Fibrosis Clinics, United Kingdom, 2009
    Personal Author:
    Seddon, Paul; Fidler, Katy; Raman, Sundhya; Wyatt, Hilary; Ruiz, Gary; Elston, Caroline; Perrin, Felicity; Gyi, Khin; Bilton, Diana; Drobniewski, Francis; Newport, Melanie;
    Published:
    Jul 2013
    Source:
    Emerg Infect Dis. 19(7):1128-1130.
    Description:
    Incidence of pulmonary infection with nontuberculous mycobacteria (NTM) is increasing among persons with cystic fibrosis (CF). We assessed prevalence and management in CF centers in the United Kingdom and found 5.0% of 3,805 adults and 3.3% of 3,317 ...
    File Type:
    Filetype[PDF - 296.21 KB]
  4. Impact of Genotyping of Mycobacterium tuberculosis on Public Health Practice in Massachusetts
    Personal Author:
    Miller, Ann C.; Sharnprapai, Sharon; Suruki, Robert; Corkren, Edward; Nardell, Edward A.; Driscoll, Jeffrey R.; McGarry, Michael; Taber, Harry; Etkind, Sue;
    Published:
    Nov 2002
    Source:
    Emerg Infect Dis. 8(11):1285-1289.
    Description:
    Massachusetts was one of seven sentinel surveillance sites in the National Tuberculosis Genotyping and Surveillance Network. From 1996 through 2000, isolates from new patients with tuberculosis (TB) underwent genotyping. We describe the impact that g...
    File Type:
    Filetype[PDF - 211.43 KB]
  5. Estimated Costs of False Laboratory Diagnoses of Tuberculosis in Three Patients
    Personal Author:
    Northrup, Jill M.; Miller, Ann C.; Nardell, Edward; Sharnprapai, Sharon; Etkind, Sue; Driscoll, Jeffrey; McGarry, Michael; Taber, Harry W.; Elvin, Paul; Qualls, Noreen L.; Braden, Christopher R.;
    Published:
    Nov 2002
    Source:
    Emerg Infect Dis. 8(11):1264-1270.
    Description:
    We estimated direct medical and nonmedical costs associated with a false diagnosis of tuberculosis (TB) caused by laboratory cross-contamination of Mycobacterium tuberculosis cultures in Massachusetts in 1998 and 1999. For three patients who received...
    File Type:
    Filetype[PDF - 337.60 KB]